Jeffrey D. Kahl
Directeur Technique/Scientifique/R&D chez Azaya Therapeutics, Inc.
Profil
Jeffrey D.
Kahl is Senior Director is Research and Development for Azaya Therapeutics, Inc. Prior to joining Azaya, he was Senior Director of Research and Development for BioNumerik Pharmaceuticals.
Dr. Kahl received a PhD from Texas Tech University.
Postes actifs de Jeffrey D. Kahl
| Sociétés | Poste | Début |
|---|---|---|
Azaya Therapeutics, Inc.
 Azaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Azaya Therapeutics, Inc. develops pharmaceutical products and systems. The firm offers contract development and manufacturing services, such as chemical testing, liposomal manufacturing services to speed drug development and regulatory progress for pharmaceutical, medical device developers and meet customers’ academic or commercial needs. The company was founded by John C. Kerr in 2003 and is headquartered in San Antonio, TX. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Jeffrey D. Kahl
| Sociétés | Poste | Fin |
|---|---|---|
BioNumerik Pharmaceuticals, Inc.
 BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Directeur Technique/Scientifique/R&D | - |
Formation de Jeffrey D. Kahl
| Texas Tech University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Azaya Therapeutics, Inc.
Azaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Azaya Therapeutics, Inc. develops pharmaceutical products and systems. The firm offers contract development and manufacturing services, such as chemical testing, liposomal manufacturing services to speed drug development and regulatory progress for pharmaceutical, medical device developers and meet customers’ academic or commercial needs. The company was founded by John C. Kerr in 2003 and is headquartered in San Antonio, TX. | Health Technology |
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Health Technology |
